GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inotiv Inc (STU:BS50) » Definitions » Cyclically Adjusted Book per Share

Inotiv (STU:BS50) Cyclically Adjusted Book per Share : €4.61 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Inotiv Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Inotiv's adjusted book value per share for the three months ended in Mar. 2024 was €7.357. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €4.61 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Inotiv's average Cyclically Adjusted Book Growth Rate was 24.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 54.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 26.00% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -0.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Inotiv was 54.80% per year. The lowest was -14.40% per year. And the median was -8.35% per year.

As of today (2024-05-24), Inotiv's current stock price is €1.82. Inotiv's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €4.61. Inotiv's Cyclically Adjusted PB Ratio of today is 0.39.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Inotiv was 41.34. The lowest was 0.29. And the median was 0.93.


Inotiv Cyclically Adjusted Book per Share Historical Data

The historical data trend for Inotiv's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inotiv Cyclically Adjusted Book per Share Chart

Inotiv Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 4.37

Inotiv Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.76 4.09 4.37 4.40 4.61

Competitive Comparison of Inotiv's Cyclically Adjusted Book per Share

For the Diagnostics & Research subindustry, Inotiv's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inotiv's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Inotiv's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Inotiv's Cyclically Adjusted PB Ratio falls into.



Inotiv Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Inotiv's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=7.357/131.7762*131.7762
=7.357

Current CPI (Mar. 2024) = 131.7762.

Inotiv Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.789 100.560 1.034
201409 0.802 100.428 1.052
201412 0.863 99.070 1.148
201503 1.007 99.621 1.332
201506 1.126 100.684 1.474
201509 1.049 100.392 1.377
201512 1.016 99.792 1.342
201603 0.965 100.470 1.266
201606 0.910 101.688 1.179
201609 0.689 101.861 0.891
201612 0.739 101.863 0.956
201703 0.787 102.862 1.008
201706 0.777 103.349 0.991
201709 0.756 104.136 0.957
201712 0.768 104.011 0.973
201803 0.746 105.290 0.934
201806 0.836 106.317 1.036
201809 0.908 106.507 1.123
201812 0.919 105.998 1.142
201903 0.882 107.251 1.084
201906 0.868 108.070 1.058
201909 0.922 108.329 1.122
201912 0.861 108.420 1.046
202003 0.824 108.902 0.997
202006 0.745 108.767 0.903
202009 0.586 109.815 0.703
202012 0.549 109.897 0.658
202103 0.532 111.754 0.627
202106 4.650 114.631 5.345
202109 5.609 115.734 6.386
202112 21.482 117.630 24.066
202203 21.997 121.301 23.897
202206 22.756 125.017 23.986
202209 14.219 125.227 14.963
202212 10.352 125.222 10.894
202303 9.933 127.348 10.278
202306 9.883 128.729 10.117
202309 9.784 129.860 9.928
202312 9.037 129.419 9.202
202403 7.357 131.776 7.357

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Inotiv  (STU:BS50) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Inotiv's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.82/4.61
=0.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Inotiv was 41.34. The lowest was 0.29. And the median was 0.93.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Inotiv Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Inotiv's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Inotiv (STU:BS50) Business Description

Traded in Other Exchanges
Address
2701 Kent Avenue, West Lafayette, IN, USA, 47906
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.

Inotiv (STU:BS50) Headlines

No Headlines